New Endometriosis Study Findings Have Been Reported from Jose Arnaldo Shiomi da Cruz et al (Endometriosis treatment pathways in the largest private health insurance in Brazil: A real-world data study): Uterine Diseases and Conditions – Endometriosis

2026 APR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Uterine Diseases and Conditions - Endometriosis is the subject of a report. According to news reporting out of Sao Paulo, Brazil, by NewsRx editors, research stated, “Endometriosis is a prevalent chronic gynecological condition affecting women of reproductive age, characterized by ectopic endometrial-like tissue growth. Despite its significant impact on quality of life, fertility, and healthcare utilization, data on real-world treatment pathways in Brazil remain scarce.”

Financial support for this research came from Johnson and Johnson.

Our news journalists obtained a quote from the research, “This study explores the clinical and demographic characteristics, diagnostic timelines, and treatment outcomes for women undergoing surgical treatment for endometriosis within Brazil’s largest healthcare database. A retrospective cohort study was conducted using data from over 8.8 million lives within the Hapvida NotreDame portfolio. Women undergoing their first surgical procedure for endometriosis between 2006 and 2024 were included. Data on clinical characteristics, healthcare utilization, symptoms, and costs were analyzed. The cohort included 5,740 women, with a median surgical age of 37 years. We found that patients with deep endometriosis took longer to undergo surgery than those with superficial endometriosis. Following surgery, there was an increase in the number of normal deliveries and cesarean sections, along with a decrease in the number of emergency gynecological consultations. The median hospital stay for surgery was 1 day and only 66 (1.1%) patients required postoperative ICU care. Additionally, 93 (1.6%) of the patients needed early reoperation, and 239 (4.1%) experienced disease recurrence and required further surgery. The surgery for patients with deep endometriosis was 40% more expensive than for those with superficial endometriosis, and the cost of diagnostic exams for the disease was equivalent to 69% of the cost of the first surgery for endometriosis. This study provides critical insights into the real-world burden of endometriosis, emphasizing the importance of timely diagnosis and surgical intervention.”

According to the news editors, the research concluded: “The findings underline the potential for improved quality of life and healthcare utilization through optimized care pathways and resource allocation.”

For more information on this research see: Endometriosis treatment pathways in the largest private health insurance in Brazil: A real-world data study. PLOS One, 2026;21(4). PLOS One can be contacted at: Public Library Science, 1160 Battery Street, Ste 100, San Francisco, CA 94111, USA. (Public Library of Science - www.plos.org; PLOS One - www.plosone.org)

Our news journalists report that additional information may be obtained by contacting Jose Arnaldo Shiomi da Cruz, International Research and Teaching Institute, Hapvida NotreDame, Sao Paulo, Sao Paulo, Brazil. Additional authors for this research include Rodrigo Afonso da Silva Sardenberg, Carlos Augusto Lima de Campos, Breno Cordeiro Porto and Kenneth Almeida.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1371/journal.pone.0345399. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the journal PLOS One is: Public Library Science, 1160 Battery Street, Ste 100, San Francisco, CA 94111, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)